T. A. Sukontseva

T. A. Sukontseva

Auto-generated profile, based on publicly available information

T. A. Sukontseva

Pavlov First Saint Petersburg State Medical University, Health Ministry of Russian Federation

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
VBVictoria Bitsadze
Victoria Bitsadze
TST. A. Sukontseva
T. A. Sukontseva
SAS. V. Akinshina
S. V. Akinshina
Yana Yu SulinaYana Yu Sulina
Yana Yu Sulina
JKJamilya Khizroeva
Jamilya Khizroeva
AMAlexander Makatsariya
Alexander Makatsariya
The problem of sepsis and septic shock has recently become more and more actual. In obstetrics and gynaecology, the number of cases of sepsis has more than doubled over the past 10 years. The review examines the clinical forms of septic conditions, risk factors, pathogenesis of sepsis and septic shock, the main pathogens of septic conditions. Special attention is paid to neonatal sepsis. The relationship between septic shock and viral infections is considered in the context of the novel coronavirus infection caused by SARS-CoV-2 (COVID-19) pandemic. Hemostasis abnormalities have been demonstrated in patients with septic shock, including disseminated intravascular coagulation (DIC). The importance of determining the level of ADAMTS-13 to refine the forecast is discussed.

9 September 2021 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
OVOlga Voskresenskaya
Olga Voskresenskaya
VBVictoria Bitsadze
Victoria Bitsadze
JKJamilya Khizroeva
Jamilya Khizroeva
TST. A. Sukontseva
T. A. Sukontseva
MTMaria V. Tretyakova
Maria V. Tretyakova
AMAlexander Makatsariya
Alexander Makatsariya
Antiphospholipid syndrome (APS) is an autoimmune process that increases the risk of arterial and venous thrombosis. The mechanism of damage to the central nervous system (CNS) can be not only due to thrombosis, but also antiphospholipid antibodies (APA) circulating in the peripheral blood. The latter can damage the cerebral vascular endothelium, alter the resistance of the blood-brain barrier and penetrate into the central nervous system, exerting a damaging effect on astroglia and neurons, as evidenced by the release of neurospecific proteins into the peripheral bloodstream. The role of APS in developing cerebral ischemia, migraine, epilepsy, chorea, transverse myelitis, multiple sclerosis, cognitive impairment and mental disorders, as well as the peripheral nervous system is described. It should also be noted about a role of APS for emerging neurological disorders in COVID-19, enabled apart from thrombogenesis due to APA via 2 potential mechanisms - molecular mimicry and neoepitope formation. Further study of the APS pathogenesis and interdisciplinary interaction are necessary to develop effective methods for patient management.